Novocure

It started when Kyle Garcia began mixing up words in conversation with his wife, Caroline. The following day, when the 37-year-old athlete complained of a raging headache, a trip to the emergency room confirmed the couple’s worst fears: This was brain cancer.   While this journey hasn’t been easy, Kyle says: “We are grateful for today, and we focus on what matters most: faith, family and friends. After all, you can’t stop the waves. But you can learn to surf them.” Read Kyle’s story here: https://lnkd.in/gyW7XFXF

Buildings across the United States will light up blue for Mesothelioma Awareness Day on September 26. Each year, an estimated 3,000 people in the United States are diagnosed with #mesothelioma. The leading cause of this rare form of cancer is prior exposure to asbestos. Increased awareness of risk factors for mesothelioma may contribute to preventing asbestos exposure and earlier diagnosis of the tumor. If you are out with someone and spot a building lit up in blue colors, let them know why. #lighttheworldblue #curemeso

If you saw someone struggling to carry their bags onto a bus, what would you do? Franziska Oldenburg, Manager, Post-Market Safety Medical Review, has always been the person who steps in to help others. “I always want to help people wherever and whenever I can, so that's what drew me to Novocure,” says Franziska. Franziska, who is trained as a pharmacist, leads the medical review team in post-market safety, ensuring that any adverse event reports they are logged and reported properly. Our patient-forward mission aligned with her motivation to positively impact peoples’ lives. Our corporate values of innovation and drive resonate with her, too. “I always try to question our status quo a little bit, so if I find a way to improve things, then I try to do it,” she says. “For innovation, it's also important to have drive, because it's nice to have all these ideas, but then you also need to have drive to really implement them and then to make sure that they are done in a timely manner.” Learn more about our values: https://lnkd.in/dDMSzKv #WeAreNovocure #innovation #drive #safety #pharmacist

We are thrilled to be in Barcelona at the #ESMO2024 Congress of the European Society for Medical Oncology. Visit us at the Novocure booth 420 in Hall 3 to learn about Tumor Treating Fields #TTFields therapy. Our team looks forward to connecting with oncology experts, to make a difference for patients facing aggressive forms of cancer. #ESMO24

We are excited to be at the International Association for the Study of Lung Cancer (#IASLC) 2024 World Conference on Lung Cancer (#WCLC24) in San Diego! Visit us at the booth 2908 to learn about the science and clinical evidence of our innovative cancer therapy Tumor Treating Fields #TTFields. We look forward to connecting with oncology experts and making a difference for patients.

Shelly Zaugg has always adored her family, which includes her husband of 30 years, Gary, and three grown children.   Since her glioblastoma diagnosis in November, Shelly says she’s developed an even greater appreciation for the time they get to spend together: dinners, vacations, a recent trip to the Nascar XFINITY Series in her home state of Iowa to see her nephew compete. She does all of these things while using our Tumor Treating Fields therapy.   “I’m enjoying today,” she said. “Anything can happen at any time, so you have to savor right now as best you can. It’s a blessing you get to see it.”   For Shelly, a big part of enjoying life comes from attending her daughter’s softball games. Using TTFields therapy, Shelly travels all over the country to see Grace compete at the college level with the Kirkwood Eagles of Cedar Rapids, Iowa. Recently, Shelly wore her device to the World Series of Softball in Washington, D.C., where her daughter’s team became runners-up for the championship title.   “It means the world to me that my mom is there,” Grace said. “She’s one of the most hard-working, kind, giving people there is, and I’m thankful that there are things like TTFields therapy out there to help her, and that she’s willing to try it out.” Grace will continue her softball career at a four-year university next fall, and Shelly plans to continue cheering as hard as she can for as long as she can. Read Shelly's story here: https://lnkd.in/dzx8ifNH #patientforward #TTFields

It’s official, Novocure’s North American Flagship office in the heart of downtown #Portsmouth, New Hampshire is open! Our CFO (and future CEO), Ashley Cordova and Executive Chairman, William Doyle, led the ceremonial ribbon-cutting surrounded by #TeamNovocure and very special guests. A special thank you to Governor Chris Sununu, U.S. Representative Chris Pappas, U.S. Senators Maggie Hassan and Jeanne Shaheen, and Portsmouth Mayor Deaglan McEachern for attending the ceremony and sharing their remarks with the audience. The grand opening of this state-of-the-art facility marks a significant milestone for our company and exemplifies our steadfast commitment to advancing innovation in cancer care and our investment in New Hampshire’s vibrant #MedTech and life sciences ecosystem. This building will serve as a hub for our expanding workforce in the region and house a world-class training center for our innovative Tumor Treating Fields therapy. We look forward to continuing our work at this new facility to support patients around the world and foster long-term economic growth throughout the Seacoast region. #WeAreNovocure 

Today at Novocure we are celebrating the accomplishments of our CEO, Asaf Danziger, who announced his retirement after 22 years leading the company. We are also celebrating that our next CEO is Ashley Cordova, our current CFO. We are deeply grateful to Asaf for his leadership and commitment to our entire organization and the patients we serve. And we look forward to our next exciting chapter with Ashley as CEO as we remain patient-forward in our focus and committed to Novocure’s mission to extend survival in aggressive forms of cancer. Read the full press release here: https://lnkd.in/eBzTX5NS #WeAreNovocure #PatientForward

Michael David Patz is passionate about making a positive impact for patients—and so is his team. With a background in neuroscience and biomedical imaging, David, Associate Manager, Post-Market Case Investigation, leads six post-market safety associates based in the U.S., Germany, Switzerland and Poland. “I work with a really great team,” he says. “We have a solid group of people who are always willing to lend a hand to a colleague.” If a patient reports an adverse event while using our device, our colleagues in medical safety investigate. This is part of ensuring the continued safety of our therapy, in line with our mission to extend survival in some of the most aggressive forms of cancer. “We're all working towards our common goal of innovating, creating, maintaining a safe device ongoing into the future,” he says. #WeAreNovocure #medtech #lifesciences #NewHampshire 

Katie Meyer, our Vice President of Public Affairs, recently sat down with James Villarrubia and Dyan Finkhousen on the Ecosystemic Futures podcast to discuss the importance of incentives in healthcare R&D. Investing in R&D is pivotal to ensuring new treatments are brought to market and into the hands of patients. At Novocure, we are committed to working with government leaders and patient advocates to ensure new policies expand access to lifesaving treatments. “One of the most compelling ways to communicate the impact of policies is to bring it all the way to the patient level and ask: what impact could this policy have on the person who is receiving healthcare?” – Katie Meyer #healthcaretechnology #healthcareinnovation The views represented in the podcast are those of Katie and not necessarily the views of Novocure.